Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.
This article was originally published on MedicalXpress.com
Novo Nordisk to pay $2 billion for new weight loss drug
You may also be interested in:
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
5 Popular Supplements in Canada for Optimal Health and Wellness
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
Read More:
-
At the height of the COVID-19 pandemic, firearm violence surpassed motor vehicle accidents as the leading cause of death among US children. A new study [...]
-
New Curtin University research has revealed child food insecurity in developed countries is not solely driven by poverty but is also strongly influenced by factors [...]
-
Researchers at Oregon Health & Science University’s Center for Mental Health Innovation have discovered that maternal diet during pregnancy, specifically during the third trimester, may [...]
